Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy

NCT03813056 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Fuchs Endothelial Dystrophy

Interventions

DRUG: Glanatec
DRUG: Optive, Ophthalmic Solution
PROCEDURE: Descemet Membrane Endothelial Keratoplasty

Sponsor

Michael D. Straiko, MD

Collaborators

[object Object]
[object Object]